Nasdaq or NYSE related Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026
Nasdaq or NYSE listed Biotechnology: Pharmaceutical Preparations industry Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Biotechnology: Pharmaceutical Preparations industry Largest Companies List by Market Cap as of August 2026
-
World Rank (Aug-2026)7,864Market Cap (Aug-2026)1.363 Billion USDWorld Rank (Jan-05-2024)19,708Market Cap (Jan-05-2024)0.141 Billion USDWorld Rank (Jul-30-2023)18,336Market Cap (Jul-30-2023)0.189 Billion USDWorld Rank (Dec-25-2022)12,953Market Cap (Dec-25-2022)0.460 Billion USDWorld Rank (Jan-07-2022)14,870Market Cap (Jan-07-2022)0.40 Billion USDAnnual Net Income in USD-696 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website
-
Alpha Tau Medical Ltd.
World Rank (Aug-2026)7,981Market Cap (Aug-2026)1.328 Billion USDWorld Rank (Jan-05-2024)17,815Market Cap (Jan-05-2024)0.202 Billion USDWorld Rank (Jul-30-2023)16,551Market Cap (Jul-30-2023)0.265 Billion USDWorld Rank (Dec-25-2022)17,769Market Cap (Dec-25-2022)0.210 Billion USDCompany Website -
Monte Rosa Therapeutics Inc.
World Rank (Aug-2026)8,001Market Cap (Aug-2026)1.322 Billion USDWorld Rank (Jan-05-2024)15,682Market Cap (Jan-05-2024)0.304 Billion USDWorld Rank (Jul-30-2023)14,960Market Cap (Jul-30-2023)0.350 Billion USDWorld Rank (Dec-25-2022)14,146Market Cap (Dec-25-2022)0.384 Billion USDWorld Rank (Jan-07-2022)10,718Market Cap (Jan-07-2022)0.79 Billion USDAnnual Revenue in USD124 Million USDAnnual Net Income in USD-39 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website -
Schrodinger Inc.
World Rank (Aug-2026)8,016Market Cap (Aug-2026)1.316 Billion USDWorld Rank (Jan-05-2024)5,184Market Cap (Jan-05-2024)2.332 Billion USDWorld Rank (Jul-30-2023)3,873Market Cap (Jul-30-2023)3.545 Billion USDWorld Rank (Dec-25-2022)7,039Market Cap (Dec-25-2022)1.344 Billion USDWorld Rank (Jan-07-2022)5,797Market Cap (Jan-07-2022)2.26 Billion USDAnnual Revenue in USD256 Million USDAnnual Net Income in USD-103 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileSchrodinger is the scientific leader in developing state of the art chemical simulation software for use in pharmaceutical, Biotechnology and Materials Research company. The headquarters is in USA.
Facts About CompanySchrodinger Annual Total Revenue for year ending Dec-2022 was 180 million USD and and Net loss for year ending Dec-2022 was -149 million USD.
Schrodinger Annual Total Revenue for year ending Dec-2021 was 137 million USD and and Net loss for year ending Dec-2021 was -100 million USD.
As on 2022, Schrodinger has 787 employees.
Company Website -
Cullinan Oncology Inc.
World Rank (Aug-2026)8,035Market Cap (Aug-2026)1.309 Billion USDWorld Rank (Jan-05-2024)13,291Market Cap (Jan-05-2024)0.447 Billion USDWorld Rank (Jul-30-2023)14,109Market Cap (Jul-30-2023)0.401 Billion USDWorld Rank (Dec-25-2022)12,838Market Cap (Dec-25-2022)0.469 Billion USDWorld Rank (Jan-07-2022)11,894Market Cap (Jan-07-2022)0.64 Billion USDAnnual Net Income in USD-220 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website -
Inhibrx Inc.
World Rank (Aug-2026)8,088Market Cap (Aug-2026)1.296 Billion USDWorld Rank (Jan-05-2024)6,046Market Cap (Jan-05-2024)1.809 Billion USDWorld Rank (Jul-30-2023)7,998World Rank (Dec-25-2022)7,998Market Cap (Dec-25-2022)1.081 Billion USDWorld Rank (Jan-07-2022)8,138Market Cap (Jan-07-2022)1.29 Billion USDAnnual Revenue in USD1 Million USDAnnual Net Income in USD-140 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileInhibrx is a Clinical Stage Biotechnology company developed a diverse pipeline of therapeutic candidates specifically designed to leverage the power of core sdAb (single-domain antibody) platform and protein engineering expertise. The company annual revenue is 34.1 million USD and 80 employees as on 2020. The headquarters is in USA.Company Website -
Corvus Pharmaceuticals
World Rank (Aug-2026)8,245Market Cap (Aug-2026)1.253 Billion USDWorld Rank (Jan-05-2024)21,283Market Cap (Jan-05-2024)0.103 Billion USDWorld Rank (Jul-30-2023)21,344Market Cap (Jul-30-2023)0.107 Billion USDWorld Rank (Dec-25-2022)26,383Market Cap (Dec-25-2022)0.039 Billion USDWorld Rank (Jan-07-2022)23,020Market Cap (Jan-07-2022)0.10 Billion USDAnnual Net Income in USD-15 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website -
Omeros Corporation
World Rank (Aug-2026)8,269Market Cap (Aug-2026)1.244 Billion USDWorld Rank (Jan-05-2024)18,164Market Cap (Jan-05-2024)0.190 Billion USDWorld Rank (Jul-30-2023)16,148Market Cap (Jul-30-2023)0.285 Billion USDWorld Rank (Dec-25-2022)19,264Market Cap (Dec-25-2022)0.159 Billion USDWorld Rank (Jan-07-2022)15,000Market Cap (Jan-07-2022)0.39 Billion USDAnnual Net Income in USD-3 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileOmeros is a Pharmaceutical Industry through novel discovery, strategic translational research and vigorous clinical programs. The company annual revenue is 13.5 million USD, total assets is 136.9 million USD and 265 employees as on 2020. The headquarters is in USA.Company Website -
MannKind Corporation
World Rank (Aug-2026)8,298Market Cap (Aug-2026)1.238 Billion USDWorld Rank (Jan-05-2024)8,442Market Cap (Jan-05-2024)1.030 Billion USDWorld Rank (Jul-30-2023)7,743Market Cap (Jul-30-2023)1.224 Billion USDWorld Rank (Dec-25-2022)7,058Market Cap (Dec-25-2022)1.340 Billion USDWorld Rank (Jan-07-2022)9,303Market Cap (Jan-07-2022)1.02 Billion USDAnnual Revenue in USD349 Million USDAnnual Net Income in USD6 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileMankind Corporation is a biopharmaceutical company with headquarters is in California, USA. It develops cutting-edge therapeutic products and technologies that help people take control of their health.Company WebsiteWikipedia -
Savara
World Rank (Aug-2026)8,806Market Cap (Aug-2026)1.105 Billion USDWorld Rank (Jan-05-2024)11,588Market Cap (Jan-05-2024)0.591 Billion USDWorld Rank (Jul-30-2023)13,226Market Cap (Jul-30-2023)0.464 Billion USDWorld Rank (Dec-25-2022)18,880Market Cap (Dec-25-2022)0.171 Billion USDWorld Rank (Jan-07-2022)20,538Market Cap (Jan-07-2022)0.15 Billion USDAnnual Net Income in USD-119 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website